Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446570
Status:
COMPLETED
Last Update Posted:
2024-06-06
First Post:
2024-05-31
Brief Title:
Phase II Study of DurvalumabMEDI4736 Tremelimumab in Pulmonary Sarcomatoid Carcinoma
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Organization Data
Organization:
Seoul National University Hospital
Class:
OTHER
Study ID:
ESR-16-12012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seoul National University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Korean Cancer Study Group | OTHER |